Ftse Mib
33.241,64
0,04%
DAX
19.083,84
0,43%
S&P 500
5.917,11
0,00%
NASDAQ
18.966,14
-0,11%
Bitcoin
97.760,87
3,61%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Italia BIT Biogen Inc (1BIIB) Biogen Inc (1BIIB) Notizie

Biogen Inc

1BIIB
146,95
0,00 (0,00%)
Ultimo aggiornamento: 13:21:05
Dati in Delay di 15 minuti
Borsa: Italia
Tipo: Azione Ordinaria
Valuta: EUR

Ultime notizie

Data Ora Fonte Titolo
19/11/202407:00UKREGDapirolizumab Pegol Phase 3 Data Presented at the American..
14/11/202417:23UKREGEisai Receives Positive Opinion from the CHMP in the..
31/10/202400:30UKREGEisai Presents Data on Benefits of Long-Term Administration..
29/10/202423:00UKREGBiogen and Neomorph Announce Multi-Target Research..
29/10/202413:00UKREGBiogen Appoints Daniel Quirk, MD, as Chief Medical Officer
28/10/202413:30UKREGMichael McDonnell, Executive Vice President and Chief..
27/10/202402:15UKREGBiogen Presents Positive Results from Phase 2 IGNAZ Study of..
24/10/202413:30UKREGBiogen to Present New Data at the Clinical Trials on..
22/10/202413:30UKREGBiogen Announces Late Breaker and New Data Presentations at..
09/10/202413:30UKREGBiogen Receives U.S. FDA Breakthrough Therapy Designation..
08/10/202413:30UKREGNew Higher Dose Nusinersen Efficacy and Safety Data..
24/9/202407:00UKREGUCB and Biogen Announce Positive Topline Results From Phase..
12/9/202413:30UKREGBiogen Board Appoints Two New Independent Directors
04/9/202413:30UKREGBiogen Announces Positive Topline Results from Study of..
30/7/202423:15UKREGNew Clinical Data Demonstrates Three Years of Continuous..
30/7/202413:30UKREGBiogen, Beckman Coulter and Fujirebio to Collaborate on..
26/7/202413:20UKREGUpdate on Regulatory Review of Lecanemab for Early..
02/7/202415:16GLOBEBiogen Completes Acquisition of Human Immunology Biosciences
28/6/202401:39GLOBE“LEQEMBI®” (Lecanemab) for the Treatment of Alzheimer’s..
24/6/202413:30GLOBETOFIDENCE™ (tocilizumab), a Biosimilar Referencing..
10/6/202401:37GLOBEFDA Accepts Eisai’s Filing of LEQEMBI® (lecanemab-irmb)..
30/5/202422:51GLOBEBiogen Receives European Commission Approval for..
22/5/202413:30GLOBEBiogen Bolsters Late-Stage Pipeline, Expands Immunology..
16/5/202413:30GLOBEBiogen and Ionis Announce Topline Phase 1/2 Study Results of..
15/5/202401:33GLOBEEisai Initiates Rolling Biologics License Application to US..
25/4/202422:05GLOBEBiogen Receives Positive CHMP Opinion for TOFIDENCE™..
06/3/202413:30GLOBENew Biomarker Data Add Further Evidence Supporting the..
04/3/202422:15GLOBEBiogen Highlights New Data at the International Conference..
23/2/202413:00GLOBEBiogen’s QALSODY® (tofersen), the First Therapy to Treat..
12/2/202422:06GLOBEBiogen Received European Commission Approval for SKYCLARYS®..
31/1/202413:30GLOBEBiogen to Realign Resources for Alzheimer's Disease..
19/12/202313:30GLOBECentralized Marketing Authorizations of Generic Versions of..
15/12/202315:05GLOBECHMP Issues Positive Opinion for Biogen’s SKYCLARYS®..
14/12/202312:30GLOBEZURZUVAE™ (zuranolone) CIV, a Landmark Oral Treatment for..
Apertura: Min: Max:
Chiusura: 146,95

La tua Cronologia

BIT
1BIIB
Biogen
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network